Our top pick for
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Albemarle Corp (ALB) is a leading specialty chemicals business with stocks listed in the US. It opened the day at US$222.315 after a previous close of US$224.79. During the day the price has varied from a low of USD221.64 to a high of USD228.525. The latest price was USD226.86 (25 minute delay). Albemarle is listed on the NYSE. All prices are listed in US Dollars.
|52-week range||US$162.0742 - US$289.9527|
|50-day moving average||US$224.5464|
|200-day moving average||US$227.6505|
|Dividend yield||US$1.565 (0.74%)|
|Earnings per share (TTM)||US$2.37|
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2022-06-17)||6.99%|
|1 month (2022-05-27)||-16.26%|
|3 months (2022-03-24)||5.94%|
|6 months (2021-12-27)||-2.68%|
|1 year (2021-06-25)||36.03%|
|2 years (2020-06-26)||203.94%|
|3 years (2019-06-27)||226.32%|
|5 years (2017-06-27)||117.15%|
Valuing Albemarle stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Albemarle's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Albemarle's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 90x. In other words, Albemarle shares trade at around 90x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Albemarle's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.4943. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Albemarle's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Albemarle's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$1 billion (£0.0 million).
The EBITDA is a measure of a Albemarle's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||US$3.6 billion|
|Operating margin TTM||20.94%|
|Gross profit TTM||US$1 billion|
|Return on assets TTM||4.37%|
|Return on equity TTM||6.07%|
|Market capitalisation||US$25 billion|
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Albemarle.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 41.74
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Albemarle's overall score of 41.74 (as at 01/01/2019) is pretty weak – landing it in it in the 84th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Albemarle is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 21.59/100
Albemarle's environmental score of 21.59 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Albemarle is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 15.41/100
Albemarle's social score of 15.41 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Albemarle is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 13.74/100
Albemarle's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Albemarle is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Albemarle scored a 1 out of 5 for controversy – the highest score possible, reflecting that Albemarle has managed to keep its nose clean.
|Total ESG score||41.74|
|Total ESG percentile||84.08|
|Environmental score percentile||7|
|Social score percentile||7|
|Governance score percentile||7|
|Level of controversy||1|
Dividend payout ratio: 29.46% of net profits
Recently Albemarle has paid out, on average, around 29.46% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.74% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Albemarle shareholders could enjoy a 0.74% return on their shares, in the form of dividend payments. In Albemarle's case, that would currently equate to about $1.565 per share.
While Albemarle's payout ratio might seem fairly standard, it's worth remembering that Albemarle may be investing much of the rest of its net profits in future growth.
Albemarle's most recent dividend payout was on 1 July 2022. The latest dividend was paid out to all shareholders who bought their shares by 9 June 2022 (the "ex-dividend date").
Albemarle's shares were split on a 2:1 basis on 2 March 2007. So if you had owned 1 share the day before the split, the next day you would own 2 shares. This wouldn't directly have changed the overall worth of your Albemarle shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Albemarle shares which in turn could have impacted Albemarle's share price.
Over the last 12 months, Albemarle's shares have ranged in value from as little as US$162.0742 up to US$289.9527. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Albemarle's is 1.5286. This would suggest that Albemarle's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
Steps to owning and managing Leo lithium shares.
Steps to owning and managing Besra Gold shares.
Steps to owning and managing The Lottery Corporation shares.
finder.com.au is one of Australia's leading comparison websites. We compare from a wide set of banks, insurers and product issuers. We value our editorial independence and follow editorial guidelines.
finder.com.au has access to track details from the product issuers listed on our sites. Although we provide information on the products offered by a wide range of issuers, we don't cover every available product or service.
Please note that the information published on our site should not be construed as personal advice and does not consider your personal needs and circumstances. While our site will provide you with factual information and general advice to help you make better decisions, it isn't a substitute for professional advice. You should consider whether the products or services featured on our site are appropriate for your needs. If you're unsure about anything, seek professional advice before you apply for any product or commit to any plan.
Products marked as 'Promoted' or 'Advertisement' are prominently displayed either as a result of a commercial advertising arrangement or to highlight a particular product, provider or feature. Finder may receive remuneration from the Provider if you click on the related link, purchase or enquire about the product. Finder's decision to show a 'promoted' product is neither a recommendation that the product is appropriate for you nor an indication that the product is the best in its category. We encourage you to use the tools and information we provide to compare your options.
Where our site links to particular products or displays 'Go to site' buttons, we may receive a commission, referral fee or payment when you click on those buttons or apply for a product. You can learn more about how we make money here.
When products are grouped in a table or list, the order in which they are initially sorted may be influenced by a range of factors including price, fees and discounts; commercial partnerships; product features; and brand popularity. We provide tools so you can sort and filter these lists to highlight features that matter to you.
We try to take an open and transparent approach and provide a broad-based comparison service. However, you should be aware that while we are an independently owned service, our comparison service does not include all providers or all products available in the market.
Some product issuers may provide products or offer services through multiple brands, associated companies or different labelling arrangements. This can make it difficult for consumers to compare alternatives or identify the companies behind the products. However, we aim to provide information to enable consumers to understand these issues.
Providing or obtaining an estimated insurance quote through us does not guarantee you can get the insurance. Acceptance by insurance companies is based on things like occupation, health and lifestyle. By providing you with the ability to apply for a credit card or loan, we are not guaranteeing that your application will be approved. Your application for credit products is subject to the Provider's terms and conditions as well as their application and lending criteria.